Hamad Medical Corporation (HMC) has further solidified its key role in advancing healthcare in Qatar by hosting the ESMO Advanced Course on Breast Cancer, titled “Filling the Gaps Following Progression on CDK4/6 in Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer,” led by Dr. Salha Bujassoum, Chairperson of Medical Oncology and Palliative Care Medicine, as reported by The Peninsula.
This groundbreaking event, the first of its kind in Qatar, highlighted innovative strategies for managing advanced breast cancer, particularly for patients whose condition progresses after treatment with CDK4/6 inhibitors. By bringing together global expertise and fostering dynamic discussions, the course further cemented Qatar’s position as a leader in oncology education.
More than 100 leading oncologists, researchers, and healthcare professionals from around the world participated in the course, focusing on addressing the challenges of advanced breast cancer care. Delegates from countries such as Qatar, Saudi Arabia, the United Arab Emirates, Italy, France, Austria, Kuwait, Oman, and Spain shared ideas and best practices, engaging in interactive case discussions and expert-led panels that provided real-world insights and highlighted the latest clinical innovations.
Under Dr. Bujassoum’s leadership, the course emphasized evidence-based practices, personalized treatment plans, and the integration of novel therapies into clinical settings. It bridged crucial gaps in care and inspired a unified commitment to improving patient outcomes globally.
Dr. Bujassoum stated, “This event marks a transformative milestone in advancing breast cancer care and reflects Qatar’s rising prominence as a global hub for oncology education. Our commitment to improving patient outcomes remains steadfast, and this course has provided us with invaluable insights and strategies to meet the evolving needs of our patients.”
She further added, “The collaboration among experts from various countries highlights the importance of sharing knowledge and fostering partnerships. Together, we can develop innovative solutions to enhance the quality of care for breast cancer patients both locally and globally.”
Following the remarkable success of this inaugural ESMO course, Qatar is poised to host more high-impact medical events, with the insights and partnerships formed during this event set to redefine care standards for breast cancer patients worldwide.
